Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07232355Recruiting

Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling

Role: collaborator

NCT03429582Not ApplicableCompleted

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

Role: collaborator

NCT03084081Not ApplicableCompleted

An Innovative Treatment for Cervical Precancer (UH3)

Role: collaborator

NCT04472455Completed

Mobile High-Resolution Microendoscopy (mHRME) for the Detection of Cervical Dysplasia in El Salvador

Role: collaborator

NCT02814448Not ApplicableCompleted

An Innovative Treatment for Cervical Pre Cancer

Role: collaborator

All 5 trials loaded